Literature DB >> 26509733

The effect of lipopolysaccharide-induced obesity and its chronic inflammation on influenza virus-related pathology.

Sun-Young Ahn1, Sung-Hwa Sohn1, Sang-Yeon Lee1, Hye-Lim Park1, Yong-Wook Park2, Hun Kim2, Jae-Hwan Nam3.   

Abstract

Obese individuals show increased susceptibility to infection, low vaccine efficacy, and worse pathophysiology. However, it is unclear how obesity affects these events. The aim of this study was to investigate the effect of obesity-triggered chronic inflammation on immune cells after influenza virus infection. Control and lipopolysaccharide mice, in which an osmotic pump continually released Tween saline or lipopolysaccharide, were prepared and 3 weeks later were infected with pandemic H1N1 2009 influenza A virus. In lipopolysaccharide mice, we found a reduction in macrophage activation markers in the steady state, and reduced production of pro-inflammatory cytokines including tumor necrosis factor-α, interleukin-1β, and interleukin-6, in restimulated peritoneal macrophages. Interestingly, lipopolysaccharide-triggered chronic inflammation exacerbated the severity of pathological symptoms in the lungs after challenge with influenza virus. Taken together, the increased severity of virus-induced symptoms in obese individuals with chronic inflammation may be, at least partially, caused by macrophage dysfunction.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Influenza virus; Low-level chronic inflammation; Obesity; Osmotic pump

Mesh:

Substances:

Year:  2015        PMID: 26509733     DOI: 10.1016/j.etap.2015.09.020

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  17 in total

1.  The healthy Nordic diet for blood glucose control: a systematic review and meta-analysis of randomized controlled clinical trials.

Authors:  Alireza Zimorovat; Mohammad Mohammadi; Nahid Ramezani-Jolfaie; Amin Salehi-Abargouei
Journal:  Acta Diabetol       Date:  2019-06-06       Impact factor: 4.280

Review 2.  The potential impacts of obesity on COVID-19.

Authors:  Ahmed Abdalazim Dafallah Albashir
Journal:  Clin Med (Lond)       Date:  2020-06-22       Impact factor: 2.659

3.  Antibody Response to SARS-CoV-2 Vaccines in People with Severe Obesity.

Authors:  Zehra Kara; Rüveyda Akçin; Ahmet Numan Demir; Harika Öykü Dinç; Halit Eren Taşkın; Bekir Kocazeybek; Volkan Demirhan Yumuk
Journal:  Obes Surg       Date:  2022-07-08       Impact factor: 3.479

4.  Comparing COVID-19 and Influenza Presentation and Trajectory.

Authors:  Anat Reiner Benaim; Jonathan A Sobel; Ronit Almog; Snir Lugassy; Tsviel Ben Shabbat; Alistair Johnson; Danny Eytan; Joachim A Behar
Journal:  Front Med (Lausanne)       Date:  2021-05-14

5.  COVID-19 in People With Schizophrenia: Potential Mechanisms Linking Schizophrenia to Poor Prognosis.

Authors:  Mohapradeep Mohan; Benjamin Ian Perry; Ponnusamy Saravanan; Swaran Preet Singh
Journal:  Front Psychiatry       Date:  2021-05-17       Impact factor: 4.157

6.  Potential pathophysiological mechanisms leading to increased COVID-19 susceptibility and severity in obesity.

Authors:  Andrej Belančić; Andrea Kresović; Valentino Rački
Journal:  Obes Med       Date:  2020-05-26

Review 7.  Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution.

Authors:  Rebekah Honce; Stacey Schultz-Cherry
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

8.  Obesity and Metabolic Surgery Society of India (OSSI) Recommendations for Bariatric and Metabolic Surgery Practice During the COVID-19 Pandemic.

Authors:  Sandeep Aggarwal; Kamal Mahawar; Manish Khaitan; Praveen Raj; Randeep Wadhawan; NandaKishore Dukkipati; Kuldeepak S Kular; Arun Prasad; Aparna Govil Bhasker; Vandana Soni; Brijesh Madhok; Sarfaraz Baig; Raj Palaniappan; H V Shivaram; Deep Goel; Vivek Bindal; Sukhvinder Saggu; Rajesh Shrivastava; Sumeet Shah; Shrihari Dhorepatil; Rajesh Khullar
Journal:  Obes Surg       Date:  2020-08-22       Impact factor: 4.129

9.  Insight into the relationship between obesity-induced low-level chronic inflammation and COVID-19 infection.

Authors:  Jihye Kim; Jae-Hwan Nam
Journal:  Int J Obes (Lond)       Date:  2020-05-22       Impact factor: 5.551

Review 10.  Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19).

Authors:  Yue Zhou; Jingwei Chi; Wenshan Lv; Yangang Wang
Journal:  Diabetes Metab Res Rev       Date:  2020-07-20       Impact factor: 8.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.